← Evidence map

ArticleTherapeutic advances in endocrinology and metabolism2019

How and why SGLT2 inhibitors should be explored as potential treatment option in diabetic retinopathy: clinical concept and methodology.

Marcus May et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31853361